Biomarin Pharmaceutical (BMRN) Return on Assets [ROA] (2010 - 2026)
Biomarin Pharmaceutical's Return on Assets [ROA] was 0.72% in Q2 2026, down 8.28 percentage points from 9.00% a year earlier and down 2.60 percentage points from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Return on Assets [ROA] (2010 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Biomarin Pharmaceutical came in at 4.79%, down 1.39 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -11.42 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was 6.17% in FY2024 (+3.64 pp), 2.54% in FY2023 (+0.25 pp), 2.29% in FY2022 (+3.37 pp) and -1.08% in FY2021 (-17.29 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q1 2022.
- Compared with a year earlier, Return on Assets [ROA] has declined for three straight quarters, with an average year-over-year change of +0.52 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2025 (a gain of 5.32 percentage points); the worst was Q4 2021 (a drop of 15.30 percentage points).
- Per Business Quant data, BMRN's Return on Assets [ROA] in the three quarters before Q2 2026 was 3.32% (Q1 2026), 4.59% (Q4 2025) and 6.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn | 0.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.72% |
| Mar 31, 2026 | 3.32% |
| Dec 31, 2025 | 4.59% |
| Sep 30, 2025 | 6.91% |
| Jun 30, 2025 | 9.00% |
| Mar 31, 2025 | 7.41% |
| Dec 31, 2024 | 6.17% |
| Sep 30, 2024 | 4.63% |
| Jun 30, 2024 | 3.68% |
| Mar 31, 2024 | 3.00% |
| Dec 31, 2023 | 2.47% |
| Sep 30, 2023 | 2.21% |
| Jun 30, 2023 | 1.54% |
| Mar 31, 2023 | 1.12% |
| Dec 31, 2022 | 2.24% |
| Sep 30, 2022 | 1.35% |
| Jun 30, 2022 | 0.89% |
| Mar 31, 2022 | 0.65% |
| Dec 31, 2021 | -1.07% |
| Sep 30, 2021 | 0.18% |
API Access
Biomarin Pharmaceutical Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();